Brain Tumors in Adults

We take on the most difficult to treat brain tumors, including glioblastomas, gliomas, astrocytomas, meningiomas, and metastatic brain tumors. We’re nationally known for providing innovative precision molecular diagnoses for brain tumors, and for our expertise in neurosurgery, neuro-oncology, and Gamma Knife®, a precisely targeted radiation treatment for complex brain tumors. We believe that, in some cases, the standard of care may be outdated and might not be the best treatment for you. That’s why we base your care plan on the tumor’s precise molecular makeup, delivering truly individualized care with compassion. We also design cutting-edge clinical trials to find promising new treatments.

Clinical Trials and Research Studies

Phase 2

CDA Chi BMS A phase II trial of nivolumab ipilimumab and short course radiotherapy in newly diagnosed glioblastoma patients with unmethylated MGMT promoter BMS-936558 and BMS-734016

Learn More

Phase 2/3

A Phase 2/3 Randomized Open-Label Study of Toca 511 a Retroviral Replicating Vector Combined With Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA (Toca5)

Learn More

Phase 1/2

Phase I-II Study of MEK 162 for Children with Low-Grade Gliomas and Other Ras/Raf/ERK Pathway Activated Tumors

Learn More

Phase 2

A phase II open-label multicenter study of ONC201 in adults with recurrent histone H3 K27M mutant glioma

Learn More